Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.

StrategyShare19, an annual, interactive event at Vanderbilt University Medical Center to showcase innovations and initiatives to advance the Medical Center’s Strategic Directions, is focusing this year on Design for Patients and Families — one of the four Strategic Directions — and efforts to enhance patient, clinician and staff experiences.

Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.

Jun. 28, 2018—A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives.

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen.